Concepedia

Author

Geoffrey Prévot

Icahn School of Medicine at Mount SinaiORCID

Also Known As

G. Prevot, Geoffrey Prevot, Geoffrey Prévot, Prevot, Geoffrey

30

Publications

622

Citations

14

H-Index

30

Concepts

All Affiliations

Icahn School of Medicine at Mount SinaiEindhoven University of TechnologyRadboud University Medical CenterRadboud University NijmegenRadboud Institute for Molecular Life Sciences
GP

About

Geoffrey Prévot is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunotherapy, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

261

2

Engineering

2

2

67

3

Biomedical Engineering

2

2

67

4

Allergy

1

1

44

5

Cell Biology

1

1

194

Geoffrey Prévot

×

13

Publications

549

Citations

13

H-Index

YearCitations

Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition

Bram Priem, Mandy M. T. van Leent, Abraham J. P. Teunissen,

Cell

2020

194

Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells

David P. Schrijver, Rutger J. Röring, Jeroen Deckers,

Nature Biomedical Engineering

2023

71

Acidic nanoparticles protect against α‐synuclein‐induced neurodegeneration through the restoration of lysosomal function

Marie-Laure Arotçarena, Federico N. Soria, Anthony Cunha,

Aging Cell

2022

46

A modular approach toward producing nanotherapeutics targeting the innate immune system

Mandy M. T. van Leent, Anu E. Meerwaldt, Alexandre Berchouchi,

Science Advances

2021

44

FSH-blocking therapeutic for osteoporosis

Sakshi Gera, Tan‐Chun Kuo, Anisa Gumerova,

eLife

2022

36

Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases

Geoffrey Prévot, Federico N. Soria, Marie-Laure Thiolat,

Bioconjugate Chemistry

2018

29

Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging

Geoffrey Prévot, Tina Kauss, Cyril Lorenzato,

International Journal of Pharmaceutics

2017

23

A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis

Samuel Bonnet, Geoffrey Prévot, Stéphane Mornet,

International Journal of Molecular Sciences

2021

23

Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy

Annelies C. Wauters, Jari F. Scheerstra, Mandy M. T. van Leent,

Nature Nanotechnology

2024

22

A cis-regulatory element controls expression of histone deacetylase 9 to fine-tune inflammasome-dependent chronic inflammation in atherosclerosis

Yaw Asare, Guangyao Yan, Christina Schlegl,

Immunity

2025

18

Page 1